Incanthera strikes skincare deal with the world’s largest healthcare retailer
Aquis-listed Incanthera PLC is moving fast as it announces a commercial deal for its high-end skincare range, Skin + CELL.
The agreement is with Marionnaud Switzerland and Austria, part of the AS Watson Group, the world’s largest international health, beauty, and lifestyle brand retailer with 16,100 stores serving 5.3 billion customers across 28 markets. Initially, the first production run was for 25,000 units, this was then doubled and now this latest deal is for 250,000 units. Chairman Tim McCarthy tells IGTV it’s expected to generate ‘significant revenues and profitability’ in 2024 and beyond.
(AI Video Summary)
Incanthera partners with Marionnaud for new Skin + CELL product
Incanthera PLC, a company based in London, has recently shared an update on its upcoming launch of a skincare product called Skin + CELL. They have partnered with Marionnaud, a well-known health and beauty retailer. Incanthera is a company that focuses on innovative technologies in dermatology and oncology. They believe that the launch of Skin + CELL will completely change their financial situation, making them a profitable company within the next year.
What is Skin + CELL and how will it be produced?
One of the reasons why Marionnaud is interested in Skin + CELL is because of its unique technology. The product is able to deliver vitamins directly through the skin barrier, which is pretty impressive. Initially, Marionnaud placed an order for 25,000 units of Skin + CELL, but this order has been increased to 50,000 units. In addition, plans for a second order of 250,000 units are already in the works.
To handle the production and packaging of the skincare product, Incanthera has partnered with a Swiss manufacturing group called Frica. This collaboration will ensure that Skin + CELL is made and packaged in a high-quality manner.
According to projections made by Stanford Capital Partners, Incanthera has the potential to generate £33 million in revenue within its third year. This is a remarkable number and shows the tremendous success that Skin + CELL could achieve. Incanthera has plans to expand its reach across Europe and Asia, with the help and support of AS Watson Group and Marionnaud.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Act on share opportunities today
Go long or short on thousands of international stocks with spread bets and CFDs.
- Get full exposure for a comparatively small deposit
- Trade on spreads from just 0.1%
- Get greater order book visibility with direct market access
See opportunity on a stock?
Try a risk-free trade in your demo account, and see whether you’re on to something.
- Log in to your demo
- Take your position
- See whether your hunch pays off
See opportunity on a stock?
Don’t miss your chance – upgrade to a live account to take advantage.
- Trade a huge range of popular stocks
- Analyse and deal seamlessly on fast, intuitive charts
- See and react to breaking news in-platform
See opportunity on a stock?
Don’t miss your chance. Log in to take advantage while conditions prevail.
Live prices on most popular markets
- Equities
- Indices
- Forex
- Commodities
Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
